Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Operating Expenses | 2,240 | 11,886 | 1,836 | 1,723 | 1,854 |
| Operating Income | -2,240 | -11,886 | -1,836 | -1,723 | -1,854 |
| Other Income | 12 | -7 | 10 | 7 | 5 |
| Pre-tax Income | -2,228 | -11,893 | -1,826 | -1,716 | -1,849 |
| Net Income Continuous | -2,228 | -11,893 | -1,826 | -1,716 | -1,849 |
| Net Income Discontinuous | N/A | -173 | -104 | -156 | 649 |
| Net Income | $-2,228 | $-12,066 | $-1,930 | $-1,872 | $-1,200 |
| EPS Basic Total Ops | -437.06 | -3,059.44 | -437.06 | -437.06 | -349.65 |
| EPS Basic Continuous Ops | -436.66 | -2,913.63 | -478.13 | -454.39 | -524.48 |
| EPS Basic Discontinuous Ops | N/A | -18.87 | -27.23 | -41.31 | 174.83 |
| EPS Diluted Total Ops | -437.06 | -3,059.44 | -437.06 | -437.06 | -349.65 |
| EPS Diluted Continuous Ops | -436.66 | -2,913.63 | -478.13 | -454.39 | -524.48 |
| EPS Diluted Discontinuous Ops | N/A | -18.87 | -27.23 | -41.31 | 174.83 |
| EBITDA(a) | $-2,229 | $-11,874 | $-1,824 | $-1,704 | $-1,834 |